U-Blot® Research Grade Anti-Human CD4 (Campath-9H)Cat. No. WA1696Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD4 (Campath-9H)Cat. No. WA1696
U-Blot® Research Grade Anti-Human CD3E (IOR-T3)Cat. No. WA1695
U-Blot® Research Grade Anti-Human CD3E (AFM15)Cat. No. WA1694
U-Blot® Research Grade Anti-Human CD39/ENTPD1 Antibody (SRF360)Cat. No. WA1693
U-Blot® Research Grade Anti-Human CD39/ENTPD1 Antibody (IPH5201)Cat. No. WA1692
U-Blot® Research Grade Anti-Human CD39/ENTPD1 (TTX-030)Cat. No. WA1691
U-Blot® Research Grade Anti-Human CD39/ENTPD1 (SRF617)Cat. No. WA1690
U-Blot® Research Grade Anti-Human CD39/ENTPD1 (PUR001)Cat. No. WA1689
U-Blot® Research Grade Anti-Human CD39/ENTPD1 (ES002)Cat. No. WA1688
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (TNB-738)Cat. No. WA1687
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (TAK-573)Cat. No. WA1686
U-Blot® Research Grade Anti-Human CD38/ADPRC 1 (TAK-169)Cat. No. WA1685